Thyro-Tab 0 — Class II drug recall D-078-2013
Terminated recall by Lloyd Inc. of Iowa, reported 2012-12-12, distributed nationwide. cGMP Deviations; does not meet in process specification requirements
| Recall number | D-078-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lloyd Inc. of Iowa, Shenandoah, IA, United States |
| Recall initiated | 2012-07-09 |
| Classified | 2012-12-03 |
| Reported by FDA | 2012-12-12 |
| Terminated | 2013-11-14 |
| Distributed | Nationwide (US) |
| Quantity | 3,813,645 tablets |
| Reason classes | cgmp |
| Lot numbers | HC31411, HE18711 |
Product
Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Reason for recall
cGMP Deviations; does not meet in process specification requirements
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-078-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.